Sono-electro-magnetic therapy for treating chronic pelvic pain syndrome in men: A randomized, placebo-controlled, double-blind trial

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Kessler, Thomas M ^a,b   Mordasini, Livio ^a   Weisstanner, Christian ^a   Jüni, Peter ^a   Da Costa, Bruno R ^a   Wiest, Roland ^a   Thalmann, George N ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; ELECTROSTIMULATION THERAPY; HUMAN; MAGNETOTHERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX; PATIENT SAFETY; PELVIS PAIN SYNDROME; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; ULTRASOUND THERAPY; CHRONIC PAIN; CLINICAL TRIAL; PELVIC PAIN;

ADULT; CHRONIC PAIN; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; HUMANS; MAGNETIC FIELD THERAPY; MALE; MIDDLE AGED; PELVIC PAIN; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 84919934953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113368     Document Type: Article

References (30)

1. Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, et al. (2010) EAU guidelines on chronic pelvic pain. Eur Urol 57: 35-48.
2. McNaughton Collins M, Barry MJ (1998) Epidemiology of chronic prostatitis. Curr Opin Urol 8: 33-37.
3. Schaeffer AJ (2008) Epidemiology and evaluation of chronic pelvic pain syndrome in men. Int J Antimicrob Agents 31 Suppl 1: S108-111.
4. Duloy AM, Calhoun EA, Clemens JQ (2007) Economic impact of chronic prostatitis. Curr Urol Rep 8: 336-339.
5. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, et al. (2004) Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 141: 581-589.
6. Shoskes DA, Katz E (2005) Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 6: 296-299.
7. Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, et al. (2011) Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 305: 78-86.
8. Nickel JC, Downey J, Ardern D, Clark J, Nickel K (2004) Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 172: 551-554.
9. Vallejo R, Kramer J, Benyamin R (2007) Neuromodulation of the cervical spinal cord in the treatment of chronic intractable neck and upper extremity pain: a case series and review of the literature. Pain Physician 10: 305-311.
10. Nnoaham KE, Kumbang J (2008) Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev: CD003222.
11. Peters KM, Carey JM, Konstandt DB (2003) Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct 14: 223-228; discussion 228.
12. Kessler TM, Z'Brun S, Haeni K, C. BF, Studer UE, et al. (2008) Combined sono-electro-magnetic therapy for treatment of refractory chronic pelvic pain syndrome: A new therapeutic possibility? Eur Urol Suppl 7: 159.
13. Mehnert U, Birzele J, Reuter K, Schurch B (2010) The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study. Journal of Urology 184: 1011-1016.
14. Propert KJ, Litwin MS, Wang Y, Alexander RB, Calhoun E, et al. (2006) Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 15: 299-305.
15. Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M, et al. (2008) Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 359: 2663-2673.
16. Vickers AJ, Altman DG (2001) Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ 323: 1123-1124.
17. Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, et al. (2004) Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol 57: 229-236.
18. Cohen J (1988) Statistical power analysis for the behavioral sciences. 2 ed. Hillsdale: Lawrence Erlbaum.
19. Melzack R, Wall PD (1965) Pain mechanisms: a new theory. Science 150: 971-979.
20. Sluka KA, Walsh D (2003) Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain 4: 109-121.
21. Butrick CW (2009) Pathophysiology of pelvic floor hypertonic disorders. Obstet Gynecol Clin North Am 36: 699-705.
22. Farmer MA, Chanda ML, Parks EL, Baliki MN, Apkarian AV, et al. (2011) Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol 186: 117-124.
23. Mordasini L, Weisstanner C, Rummel C, Thalmann GN, Verma RK, et al. (2012) Chronic pelvic pain syndrome in men is associated with reduction of relative gray matter volume in the anterior cingulate cortex compared to healthy controls. J Urol 188: 2233-2237.
24. Kothari S (2007) Neuromodulatory approaches to chronic pelvic pain and coccygodynia. Acta Neurochir Suppl 97: 365-371.
25. Lee SH, Lee BC (2009) Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology 73: 1036-1041.
26. Wöllner J, Hampel C, Kessler TM (2012) Sacral neuromodulation. BJU Int 110: 146-159.
27. Marcelissen T, Jacobs R, van Kerrebroeck P, de Wachter S (2011) Sacral neuromodulation as a treatment for chronic pelvic pain. J Urol 186: 387-393.
28. Hassouna MM, Elkelini MS (2007) Early versus late treatment of voiding dysfunction with pelvic neuromodulation. Can Urol Assoc J 1: 106-110.
29. Peters KM, Feber KM, Bennett RC (2007) A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int 100: 835-839.
30. Hrobjartsson A, Gotzsche PC (2010) Placebo interventions for all clinical conditions. Cochrane Database Syst Rev: CD003974.